Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Ricklin

Showing results (31-40 of 135) with videos related to

Pageof 14
Sort By:
British Journal of Pharmacology|November 3, 2020
Sweet turning bitter: Carbohydrate sensing of complement in host defence and diseaseRachel Hevey, Richard B Pouw, Claire Harris, et al.
Journal of Molecular Recognition : JMR|February 24, 2009
Oligohis-tags: mechanisms of binding to Ni2+-NTA surfacesSteven Knecht, Daniel Ricklin, Alex N Eberle, et al.
Nature Immunology|August 20, 2010
Complement: a key system for immune surveillance and homeostasisDaniel Ricklin, George Hajishengallis, Kun Yang, et al.
Research and Practice in Thrombosis and Haemostasis|July 25, 2022
Exploring the function of factor XIII free B subunit: Interactions with complement factors and a novel approach to identify potential binding partnersBojun Li, Clément Bechtler, Lorenz Jenny, et al.
Seminars in Immunopathology|August 4, 2011
Interactions between coagulation and complement--their role in inflammationKaterina Oikonomopoulou, Daniel Ricklin, Peter A Ward, et al.
Trends in Pharmacological Sciences|January 29, 2022
Compstatins: the dawn of clinical C3-targeted complement inhibitionChristina Lamers, Dimitrios C Mastellos, Daniel Ricklin, et al.
Immunobiology|September 12, 2012
Targeted complement inhibition as a promising strategy for preventing inflammatory complications in hemodialysisRobert A DeAngelis, Edimara S Reis, Daniel Ricklin, et al.
Nature Reviews. Nephrology|December 5, 2017
The renaissance of complement therapeuticsDaniel Ricklin, Dimitrios C Mastellos, Edimara S Reis, et al.
Molecular Immunology|August 20, 2018
Developments in anti-complement therapy; from disease to clinical trialClaire L Harris, Richard B Pouw, David Kavanagh, et al.
Expert Review of Hematology|September 13, 2014
Complement in paroxysmal nocturnal hemoglobinuria: exploiting our current knowledge to improve the treatment landscapeDimitrios C Mastellos, Daniel Ricklin, Despina Yancopoulou, et al.
Pageof 14

Showing results (31-40 of 135) with videos related to

Sort By:
Pageof 14
British Journal of Pharmacology|November 3, 2020
Sweet turning bitter: Carbohydrate sensing of complement in host defence and diseaseRachel Hevey, Richard B Pouw, Claire Harris, et al.
Journal of Molecular Recognition : JMR|February 24, 2009
Oligohis-tags: mechanisms of binding to Ni2+-NTA surfacesSteven Knecht, Daniel Ricklin, Alex N Eberle, et al.
Nature Immunology|August 20, 2010
Complement: a key system for immune surveillance and homeostasisDaniel Ricklin, George Hajishengallis, Kun Yang, et al.
Research and Practice in Thrombosis and Haemostasis|July 25, 2022
Exploring the function of factor XIII free B subunit: Interactions with complement factors and a novel approach to identify potential binding partnersBojun Li, Clément Bechtler, Lorenz Jenny, et al.
Seminars in Immunopathology|August 4, 2011
Interactions between coagulation and complement--their role in inflammationKaterina Oikonomopoulou, Daniel Ricklin, Peter A Ward, et al.
Trends in Pharmacological Sciences|January 29, 2022
Compstatins: the dawn of clinical C3-targeted complement inhibitionChristina Lamers, Dimitrios C Mastellos, Daniel Ricklin, et al.
Immunobiology|September 12, 2012
Targeted complement inhibition as a promising strategy for preventing inflammatory complications in hemodialysisRobert A DeAngelis, Edimara S Reis, Daniel Ricklin, et al.
Nature Reviews. Nephrology|December 5, 2017
The renaissance of complement therapeuticsDaniel Ricklin, Dimitrios C Mastellos, Edimara S Reis, et al.
Molecular Immunology|August 20, 2018
Developments in anti-complement therapy; from disease to clinical trialClaire L Harris, Richard B Pouw, David Kavanagh, et al.
Expert Review of Hematology|September 13, 2014
Complement in paroxysmal nocturnal hemoglobinuria: exploiting our current knowledge to improve the treatment landscapeDimitrios C Mastellos, Daniel Ricklin, Despina Yancopoulou, et al.
Pageof 14